I.st Cosmetics mall

Biotechnology, Next challenge CREATING A BETTER LIFE

Business Philosophy

Biotechnology Next Challenge Striving for a better future for humankind based on bioscience and technology

BNC KOREA researches and develops strategic application products that will lead the next-generation bio markets for medical devices, pharmaceuticals and cosmeceutical products containing physiologically active substances by processing biomaterials such as hyaluronic acid and collagen.

As a world-class biotechnology company, BNC KOREA will continue to help people live more enjoyable life through continuous research and development using cutting-edge application technology based on biomaterials.

Company Overview

  • Company Name : BNC KOREA, INC.
  • CEO: Wangyu Choi
  • Date of Incorporation: 8/1/2007
  • Employees: 111 (As of 2020)
  • Laboratory Personnel: 21persons
  • Capital: 3,873 mill. USD , as of April 2020
  • Main Business: Development and production
                 of biomaterials for medicine
BNC KOREA A Korean bio-venture company with both growth and profitability

  • 01

    Korean Bio-Venture

    • · Growth : R&D-oriented
    • · Profitability :Securing of independent finances
      for R&D through a wide range of profitable businesses
  • 02

    Differentiated Bio-tech Expertise

    • · Self-developed HA Filler technology
    • · Self-developed HA Anti-Adhesion barrier gel
      and collagen wound dressings
    • · Korea-granted patent for HA cross-linkage technology
    • · Korea-granted patent for collagen wound dressings
      containing antibiotic
  • 03

    Future Market Leadership

    • · Preventive target marketing. Aiming
      at the future marketability of certain markets,
      such as the wound dressing market.
    • · Securing new natural-medicine aesthetic
    • · Aiming for the future global
      pharmaceutical market